Towards the end of 2021, William Demant Foundation, the majority owner of Demant, donated DKK 3.5 million (USD 530,000) to UNICEF and the ACT-A programme.
The ACT-A programme (The Access to COVID-19 Tools Accelerator) is a global collaboration that seeks to accelerate fair access to COVID-19 tests, treatments and vaccines.
With William Demant Foundation being founded on care and with world health as its key sustainable goal, it was important for the Foundation to support UNICEF's fight to end the coronavirus crisis.
“With our donation, we want to take part in easing the situation for children, families and healthcare workers in vulnerable communities and do our part to get the world back on its feet,” said Lars Nørby Johansen, chair of William Demant Foundation.
- The donation, which is directed at UNICEF as the lead implementation partner of ACT-A, aims to help low-income areas with:
- In-country delivery of coronavirus vaccines
- Diagnostic tests and related technical assistance
- Oxygen systems and novel and repurposed therapeutics
- Personal protective equipment and supplies for front-line healthcare workers to work safely
- Risk communication and community engagement to promote COVID-19 vaccines, tests and treatments